![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Ortlepp J.R. Breuer J. Eitner F. Kluge K. Kluge R. Floege J. Hollweg G. Hanrath P. Joost H.-G.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.436, Iss.1, 2002-02, pp. : 145-150
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Pulmonary Renin-Angiotensin System
Current Pharmaceutical Design, Vol. 9, Iss. 9, 2003-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
Drugs, Vol. 64, Iss. 22, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inhibition of the Renin-Angiotensin System and Atrial Fibrillation in Heart Failure
Heart Drug, Vol. 5, Iss. 4, 2005-12 ,pp. :